PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1
Aging · 2023
DOI: 10.18632/aging.204739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Xiaoping Mei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang, People’s Republic of China. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang, People’s Republic of China.
- Department of Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang, People’s Republic of China.
Zitieren
APA
Mei, X., Zhou, H., Song, Z., Yang, X., Liu, X., Fei, J., Shen, Y., & Wang, X. (2023). PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1. Aging. https://doi.org/10.18632/aging.204739
Vancouver
Mei X, Zhou H, Song Z, Yang X, Liu X, Fei J, et al. PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1. Aging. 2023. doi:10.18632/aging.204739
BibTeX
@article{Mei2023,
author = {Mei, Xiaoping and Zhou, Hongkun and Song, Zhengwei and Yang, Xiaodan and Liu, Xiaorong and Fei, Jianguo and Shen, Yiyu and Wang, Xiaoguang},
title = {PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204739}
}
EUVIMED